Oncology Institute Inc.

NASDAQ: TOI · Real-Time Price · USD
3.58
-0.09 (-2.45%)
At close: Aug 15, 2025, 10:05 AM

Oncology Institute Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-64.66M -83.07M 1.66M -10.93M
Depreciation & Amortization
6.29M 5.87M 4.41M 3.34M
Stock-Based Compensation
11.15M 17.81M 27.68M 24.54M
Other Working Capital
10.97M 6.18M 7.04M -13.37M
Other Non-Cash Items
2.63M 20.79M -75.19M -33.9M
Deferred Income Tax
n/a -76K 183K -1.24M
Change in Working Capital
18.06M 2.36M -20.5M -14.49M
Operating Cash Flow
-26.54M -36.31M -61.76M -32.68M
Capital Expenditures
-3.79M -4.57M -5.53M -3.05M
Cash Acquisitions
n/a -4.46M -8.58M -9.11M
Purchase of Investments
n/a -9.6M -117.51M n/a
Sales Maturities Of Investments
50M 81.26M 126.08M n/a
Other Investing Acitivies
n/a n/a -126.08M -200K
Investing Cash Flow
46.21M 62.64M -131.61M -12.15M
Debt Repayment
-39K -101K 109.94M -7.25M
Common Stock Repurchased
n/a -1.02M -9M n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-3.53M -5.73M -8.74M 141.26M
Financial Cash Flow
-3.49M -6.85M 92.21M 154.01M
Net Cash Flow
16.18M 19.48M -101.16M 109.18M
Free Cash Flow
-30.33M -40.88M -67.28M -35.73M